These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15684211)

  • 1. Decisions about treating community-acquired pneumonia.
    Mandell L
    Ann Intern Med; 2005 Feb; 142(3):215-6. PubMed ID: 15684211
    [No Abstract]   [Full Text] [Related]  

  • 2. Summaries for patients. Can patients with pneumonia take their antibiotics at home?
    Ann Intern Med; 2005 Feb; 142(3):I30. PubMed ID: 15684200
    [No Abstract]   [Full Text] [Related]  

  • 3. Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients.
    Carratalà J; Fernández-Sabé N; Ortega L; Castellsagué X; Rosón B; Dorca J; Fernández-Agüera A; Verdaguer R; Martínez J; Manresa F; Gudiol F
    Ann Intern Med; 2005 Feb; 142(3):165-72. PubMed ID: 15684204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monotherapy in severe community-acquired pneumonia: is it worthy?
    Torres A
    Chest; 2005 Jul; 128(1):10-3. PubMed ID: 16002907
    [No Abstract]   [Full Text] [Related]  

  • 5. Performance measurement in community-acquired pneumonia: consequences intended and unintended.
    File TM; Gross PA
    Clin Infect Dis; 2007 Apr; 44(7):942-4. PubMed ID: 17342645
    [No Abstract]   [Full Text] [Related]  

  • 6. The unintended, negative consequences of the door-to-antibiotic measure for pneumonia.
    Gogol M
    Ann Intern Med; 2009 Feb; 150(3):219; author reply 220. PubMed ID: 19189914
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of community acquired pneumonia].
    Böszörményi Nagy G
    Orv Hetil; 2004 May; 145(22):1189-92. PubMed ID: 15279407
    [No Abstract]   [Full Text] [Related]  

  • 8. The unintended, negative consequences of the door-to-antibiotic measure for pneumonia.
    Srouji N
    Ann Intern Med; 2009 Feb; 150(3):220; author reply 220. PubMed ID: 19189917
    [No Abstract]   [Full Text] [Related]  

  • 9. The unintended, negative consequences of the door-to-antibiotic measure for pneumonia.
    Dean NC
    Ann Intern Med; 2009 Feb; 150(3):219; author reply 220. PubMed ID: 19189915
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of community-acquired pneumonia with levofloxacin: 500 mg once a day or 500 mg twice a day?].
    Zuck P; Bru JP
    Presse Med; 2000 May 27-Jun 3; 29(19):1062-5. PubMed ID: 10874918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.
    Querol-Ribelles JM; Tenías JM; Querol-Borrás JM; Labrador T; Nieto A; González-Granda D; Martínez I
    Int J Antimicrob Agents; 2005 Jan; 25(1):75-83. PubMed ID: 15620830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial.
    Samsa GP; Matchar DB; Harnett J; Wilson J
    Chest; 2005 Nov; 128(5):3246-54. PubMed ID: 16304269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired pneumonia: treatment at home or in the hospital?
    Aujesky D; Fine MJ
    Am J Med; 2008 Dec; 121(12):1038-40. PubMed ID: 19028194
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors.
    Leroy O; Saux P; Bédos JP; Caulin E
    Chest; 2005 Jul; 128(1):172-83. PubMed ID: 16002932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current recommendations for the treatment of community-acquired pneumonia. How to put the guidelines into practice].
    Gillissen A
    MMW Fortschr Med; 2010 Nov; 152(45):34. PubMed ID: 21319406
    [No Abstract]   [Full Text] [Related]  

  • 17. Community acquired pneumonia.
    Loeb M
    Clin Evid; 2002 Dec; (8):1546-57. PubMed ID: 12603953
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral levofloxacin in the treatment of community-acquired pneumonia.
    Nicodemo AC; Lima Nicodemo E; Idrahim KY
    Braz J Infect Dis; 2000 Apr; 4(2):61-6. PubMed ID: 10795070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community acquired pneumonia.
    Loeb M
    Clin Evid; 2002 Jun; (7):1358-68. PubMed ID: 12230751
    [No Abstract]   [Full Text] [Related]  

  • 20. Levofloxacin in the treatment of community-acquired pneumonia.
    Noreddin AM; Elkhatib WF
    Expert Rev Anti Infect Ther; 2010 May; 8(5):505-14. PubMed ID: 20455679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.